Literature DB >> 24730395

Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic function.

R Wunderlich1, A Ernst, F Rödel, R Fietkau, O Ott, K Lauber, B Frey, U S Gaipl.   

Abstract

Benign painful and inflammatory diseases have been treated for decades with low/moderate doses of ionizing radiation (LD-X-irradiation). Tissue macrophages regulate initiation and resolution of inflammation by the secretion of cytokines and by acting as professional phagocytes. Having these pivotal functions, we were interested in how activated macrophages are modulated by LD-X-irradiation, also with regard to radiation protection issues and carcinogenesis. We set up an ex-vivo model in which lipopolysaccharide pre-activated peritoneal macrophages (pMΦ) of radiosensitive BALB/c mice, mimicking activated macrophages under inflammatory conditions, were exposed to X-irradiation from 0·01 Gy up to 2 Gy. Afterwards, the viability of the pMΦ, their transmigration and chemotaxis, the phagocytic behaviour, the secretion of inflammatory cytokines and underlying signalling pathways were determined. Exposure of pMΦ up to a single dose of 2 Gy did not influence their viability and phagocytic function, an important fact regarding radiation protection. However, significantly reduced migration, but increased chemotaxis of pMΦ after exposure to 0·1 or 0·5 Gy, was detected. Both might relate to the resolution of inflammation. Cytokine analyses revealed that, in particular, the moderate dose of 0·5 Gy applied in low-dose radiotherapy for inflammatory diseases results in an anti-inflammatory cytokine microenvironment of pMΦ, as the secretion of the proinflammatory cytokine interleukin (IL)-1β was reduced and that of the anti-inflammatory cytokine transforming growth factor (TGF)-β increased. Further, the reduced secretion of IL-1β correlated with reduced nuclear translocation of nuclear factor (NF)-κB p65, starting at exposure of pMΦ to 0·5 Gy of X-irradiation. We conclude that inflammation is modulated by LD-X-irradiation via changing the inflammatory phenotype of macrophages.
© 2014 British Society for Immunology.

Entities:  

Keywords:  chemotaxis; cytokines; inflammation; macrophage; phagocytosis

Mesh:

Substances:

Year:  2015        PMID: 24730395      PMCID: PMC4260896          DOI: 10.1111/cei.12344

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  54 in total

1.  In vitro apoptosis in peripheral blood mononuclear cells induced by low-dose radiotherapy displays a discontinuous dose-dependence.

Authors:  P Kern; L Keilholz; C Forster; M H Seegenschmiedt; R Sauer; M Herrmann
Journal:  Int J Radiat Biol       Date:  1999-08       Impact factor: 2.694

2.  Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro.

Authors:  G Hildebrandt; L Maggiorella; F Rödel; V Rödel; D Willis; K-R Trott
Journal:  Int J Radiat Biol       Date:  2002-04       Impact factor: 2.694

3.  Low dose ionising radiation leads to a NF-κB dependent decreased secretion of active IL-1β by activated macrophages with a discontinuous dose-dependency.

Authors:  Barbara Lödermann; Roland Wunderlich; Silke Frey; Christine Schorn; Sonja Stangl; Franz Rödel; Ludwig Keilholz; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Int J Radiat Biol       Date:  2012-05-22       Impact factor: 2.694

Review 4.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

Review 5.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 6.  Inefficient clearance of dying cells and autoreactivity.

Authors:  U S Gaipl; A Sheriff; S Franz; L E Munoz; R E Voll; J R Kalden; M Herrmann
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 7.  A close encounter of the third kind: monocyte-derived cells.

Authors:  Alexander Mildner; Simon Yona; Steffen Jung
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

8.  Both Erk and p38 kinases are necessary for cytokine gene transcription.

Authors:  A B Carter; M M Monick; G W Hunninghake
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

Review 9.  NALPs: a novel protein family involved in inflammation.

Authors:  Jürg Tschopp; Fabio Martinon; Kimberly Burns
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

10.  Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype.

Authors:  Thorsten Hagemann; Julia Wilson; Frances Burke; Hagen Kulbe; Ninfeng Fiona Li; Annette Plüddemann; Kellie Charles; Siamon Gordon; Frances R Balkwill
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

View more
  35 in total

1.  Dying autologous cells as instructors of the immune system.

Authors:  L E Munoz; M Herrmann; C Berens
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

2.  Is anti-inflammatory radiotherapy an effective treatment in trochanteritis?

Authors:  Izaskun Valduvieco; Albert Biete; Luis A Moreno; Xavier Gallart; Angels Rovirosa; Jordi Saez; Carlos Plana; Pilar Peris
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

Review 3.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

Review 4.  Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.

Authors:  Michael Rückert; Lisa Deloch; Rainer Fietkau; Benjamin Frey; Markus Hecht; Udo S Gaipl
Journal:  Strahlenther Onkol       Date:  2018-03-02       Impact factor: 3.621

5.  DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk.

Authors:  Berthold Reichl; Andreas Block; Ulrich Schäfer; Christoph Bert; Reinhold Müller; Horst Jung; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2015-06-28       Impact factor: 3.621

6.  MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.

Authors:  Arpita Chatterjee; Elizabeth A Kosmacek; Rebecca E Oberley-Deegan
Journal:  Radiat Res       Date:  2017-02-22       Impact factor: 2.841

7.  Temporarily increased TGFβ following radon spa correlates with reduced pain while serum IL-18 is a general predictive marker for pain sensitivity.

Authors:  Miriam Kullmann; Paul F Rühle; Alexandra Harrer; Anna Donaubauer; Ina Becker; Renate Sieber; Gerhart Klein; Claudia Fournier; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Radiat Environ Biophys       Date:  2018-11-19       Impact factor: 1.925

8.  Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice.

Authors:  Hayam M Sayed; Mahmoud M Said; Nadia Y S Morcos; Mona A El Gawish; Amel F M Ismail
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

9.  Rapid assay of stem cell functionality and potency using electric cell-substrate impedance sensing.

Authors:  Michael J Rutten; Bryan Laraway; Cynthia R Gregory; Hua Xie; Christian Renken; Charles Keese; Kenton W Gregory
Journal:  Stem Cell Res Ther       Date:  2015-10-05       Impact factor: 6.832

10.  Chronic Internal Exposure to Low Dose 137Cs Induces Positive Impact on the Stability of Atherosclerotic Plaques by Reducing Inflammation in ApoE-/- Mice.

Authors:  Clélia Le Gallic; Yohann Phalente; Line Manens; Isabelle Dublineau; Marc Benderitter; Yann Gueguen; Stephanie Lehoux; Teni G Ebrahimian
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.